cabozantinib (cometriq) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

VA Big4

$151.9545 - $442.3757

VA FSS

$192.9564 - $573.9367

AUS PBS

$254.6638

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
cabozantinib s-malate 20 mg (CAPSULE) $151.9545 VA Big4
  • COMETRIQ (84)
    		•  Exelixis, Inc.
    cabozantinib s-malate 20 mg (CAPSULE) $192.9564 VA FSS
  • COMETRIQ (84)
    		•  Exelixis, Inc.
    cabozantinib s-malate 20 mg (TABLET) $254.6638 AUS PBS generic
  • Cabometyx (30)
    		•  Ipsen Pty Ltd
    cabozantinib s-malate 20 mg (TABLET) $442.3757 VA Big4
  • CABOMETYX (30)
    		•  Exelixis, Inc.
    cabozantinib s-malate 20 mg (TABLET) $573.9367 VA FSS
  • CABOMETYX (30)
    		•  Exelixis, Inc.
    cabozantinib s-malate 40 mg (TABLET) $254.6638 AUS PBS generic
  • Cabometyx (30)
    		•  Ipsen Pty Ltd
    cabozantinib s-malate 40 mg (TABLET) $436.9887 VA Big4
  • CABOMETYX (30)
    		•  Exelixis, Inc.
    cabozantinib s-malate 40 mg (TABLET) $573.9367 VA FSS
  • CABOMETYX (30)
    		•  Exelixis, Inc.
    cabozantinib s-malate 60 mg (TABLET) $254.6638 AUS PBS generic
  • Cabometyx (30)
    		•  Ipsen Pty Ltd
    cabozantinib s-malate 60 mg (TABLET) $438.9450 VA Big4
  • CABOMETYX (30)
    		•  Exelixis, Inc.
    cabozantinib s-malate 60 mg (TABLET) $573.9367 VA FSS
  • CABOMETYX (30)
    		•  Exelixis, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue